Mass Balance and Pharmacokinetics of [(14)C]Telavancin following Intravenous Administration to Healthy Male Volunteers

Yazar: Shaw, Jeng-Pyng, Cheong, Jonathan, Goldberg, Michael R., Kitt, Michael M.
Baskı/Yayın Bilgisi 2010

Intrapulmonary Distribution of Intravenous Telavancin in Healthy Subjects and Effect of Pulmonary Surfactant on In Vitro Activities of Telavancin and Other Antibiotics

Yazar: Gotfried, Mark H., Shaw, Jeng-Pyng, Benton, Bret M., Krause, Kevin M., Goldberg, Michael R., Kitt, Michael M., Barriere, Steven L.
Baskı/Yayın Bilgisi 2008

Effects of TD-5108 on Gastrointestinal Transit and Bowel Function in Health and Pharmacokinetics in Health and Constipation

Yazar: Manini, Mhd Louai, Camilleri, Michael, Goldberg, Michael, Sweetser, Seth, McKinzie, Sanna, Burton, Duane, Wong, Shekman, Kitt, Michael M., Li, Yu-Ping, Zinsmeister, Alan R.
Baskı/Yayın Bilgisi 2009

A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study

Yazar: Stryjewski, Martin E, Lentnek, Arnold, O’Riordan, William, Pullman, John, Tambyah, Paul Anantharajah, Miró, Jose M, Fowler Jr, Vance G, Barriere, Steven L, Kitt, Michael M, Corey, G Ralph
Baskı/Yayın Bilgisi 2014

Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa

Yazar: Siegal, Deborah, Lu, Genmin, Leeds, Janet M., Karbarz, Mark, Castillo, Janice, Mathur, Vandana, Hutchaleelaha, Athiwat, Sinha, Uma, Kitt, Michael, McClure, Matt, Hollenbach, Stanley J., Curnutte, John T., Conley, Pamela B., Crowther, Mark
Yayımlandı Blood Adv (2017)

Telavancin versus Standard Therapy for Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: FAST 2 Study

Yazar: Stryjewski, Martin E., Chu, Vivian H., O'Riordan, William D., Warren, Brian L., Dunbar, Lala M., Young, David M., Vallée, Marc, Fowler, Vance G., Morganroth, Joel, Barriere, Steven L., Kitt, Michael M., Corey, G. Ralph
Baskı/Yayın Bilgisi 2006

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

Yazar: Rubinstein, Ethan, Lalani, Tahaniyat, Corey, G. Ralph, Kanafani, Zeina A., Nannini, Esteban C., Rocha, Marcelo G., Rahav, Galia, Niederman, Michael S., Kollef, Marin H., Shorr, Andrew F., Lee, Patrick C., Lentnek, Arnold L., Luna, Carlos M., Fagon, Jean-Yves, Torres, Antoni, Kitt, Michael M., Genter, Fredric C., Barriere, Steven L., Friedland, H. David, Stryjewski, Martin E.
Baskı/Yayın Bilgisi 2011